Evidence map›Paper›PMID 30560944›Full record

ArticleNature communications2018

BRCA2 controls DNA:RNA hybrid level at DSBs by mediating RNase H2 recruitment.

Giuseppina D'Alessandro, Donna Rose Whelan, Sean Michael Howard, Valerio Vitelli, Xavier Renaudin, Marek Adamowicz, Fabio Iannelli, Corey Winston Jones-Weinert, MiYoung Lee, Valentina Matti and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 162 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 1 synthesis or guideline pooled it, 240 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Mechanisms and disease relevance of DNA break repair pathway choice.Nature reviews. Molecular cell biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Dual roles of NScience China. Life sciences · 2025
    Article
  19. Article
  20. Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Giuseppina D'AlessandroIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139, Italy. dalessandrogiuseppina@gmail.com.
Donna Rose WhelanDepartment of Biochemistry and Molecular Pharmacology, NYU School of Medicine, New York, NY, 10016, USA.ORCID http://orcid.org/0000-0002-7078-5443
Sean Michael HowardInstitute for Research in Biomedicine, Università della Svizzera italiana, Via Vela 6, Bellinzona, 6500, Switzerland.
Valerio VitelliIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139, Italy.
Xavier RenaudinMedical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK.
Marek AdamowiczIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139, Italy.
Fabio IannelliIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139, Italy.
Corey Winston Jones-WeinertIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139, Italy.
MiYoung LeeMedical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK.
Valentina MattiIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139, Italy.
Wei Ting C LeeDepartment of Biochemistry and Molecular Pharmacology, NYU School of Medicine, New York, NY, 10016, USA.
Michael John MortenDepartment of Biochemistry and Molecular Pharmacology, NYU School of Medicine, New York, NY, 10016, USA.
Ashok Raraakrishnan VenkitaramanMedical Research Council Cancer Unit, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK.
Petr CejkaInstitute for Research in Biomedicine, Università della Svizzera italiana, Via Vela 6, Bellinzona, 6500, Switzerland.
Eli RothenbergDepartment of Biochemistry and Molecular Pharmacology, NYU School of Medicine, New York, NY, 10016, USA.
Fabrizio d'Adda di FagagnaIFOM, the FIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139, Italy. fabrizio.dadda@ifom.eu.ORCID http://orcid.org/0000-0002-9603-5966
IFOM · ITNew York University · USUniversity of Cambridge · GBÉcole Polytechnique Fédérale de Lausanne · CHUniversità della Svizzera italiana · CHUniversity of Sussex · GB

Funding

Single-Molecule Studies of Non-Homologous DNA End JoiningR01GM108119 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTHENBERG, ELI · 2015 to 2019
$1.7M
Single-molecule studies of BRCA1-BACH1 mechanism in genomic integrityR21CA187612 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTHENBERG, ELI · 2015 to 2016
$451k
Medical Research Council MC_PC_15050Medical Research Council MC_PC_17111Medical Research Council MC_UU_12022/1Medical Research Council MC_UU_12022/8NCI NIH HHS R21 CA187612NIGMS NIH HHS R01 GM108119
6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) are toxic DNA lesions, which, if not properly repaired, may lead to genomic instability, cell death and senescence. Damage-induced long non-coding RNAs (dilncRNAs) are transcribed from broken DNA ends and contribute to DNA damage response (DDR) signaling. Here we show that dilncRNAs play a role in DSB repair by homologous recombination (HR) by contributing to the recruitment of the HR proteins BRCA1, BRCA2, and RAD51, without affecting DNA-end resection. In S/G2-phase cells, dilncRNAs pair to the resected DNA ends and form DNA:RNA hybrids, which are recognized by BRCA1. We also show that BRCA2 directly interacts with RNase H2, mediates its localization to DSBs in the S/G2 cell-cycle phase, and controls DNA:RNA hybrid levels at DSBs. These results demonstrate that regulated DNA:RNA hybrid levels at DSBs contribute to HR-mediated repair.

Indexed as

Recombinational DNA RepairBRCA1 ProteinBRCA2 ProteinCell Line, TumorDNADNA Breaks, Double-StrandedG2 PhaseGene Knockdown TechniquesHEK293 CellsHumansRad51 RecombinaseRibonuclease HRNA, Long NoncodingRNA, Small InterferingS PhaseBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanDNARAD51 protein, humanRad51 RecombinaseRibonuclease Hribonuclease HIIRNA, Long NoncodingRNA, Small Interfering

Identifiers

PMID30560944
PMCPMC6299093
OpenAlexW2903908034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.